Circulating Tumour DNA (ctDNA) Clearance With Neoadjuvant Durvalumab (D) + Tremelimumab (T) + Enfortumab Vedotin (EV) for Cisplatin-Ineligible Treatment of Muscle-Invasive Bladder Cancer(MIBC) From the Safety Run-in Cohort of the Phase 3 VOLGA Trial Grail Content Editor Circulating Tumour DNA (ctDNA) Clearance With Neoadjuvant Durvalumab (D) + Tremelimumab (T) + Enfortumab Vedotin (EV) for Cisplatin-Ineligible Treatment of Muscle-Invasive Bladder Cancer(MIBC) From the Safety Run-in Cohort of the Phase 3 VOLGA Trial Read More »
Circulating tumor DNA dynamics and treatment responses in chemotherapy-ineligible patients with unresectable Stage III NSCLC from the phase 2 DUART trial Grail Content Editor Circulating tumor DNA dynamics and treatment responses in chemotherapy-ineligible patients with unresectable Stage III NSCLC from the phase 2 DUART trial Read More »
NHS-Galleri Trial Enrolment Approaches and Participant Sociodemographic Characteristics Grail Content Editor NHS-Galleri Trial Enrolment Approaches and Participant Sociodemographic Characteristics Read More »
Time to Diagnosis Among Patients with Cancer in the US Grail Content Editor Time to Diagnosis Among Patients with Cancer in the US Read More »
Prediction of the risk of recurrence in patients with non-small-cell lung cancer using an integrated claims and electronic medical record database Grail Content Editor Prediction of the risk of recurrence in patients with non-small-cell lung cancer using an integrated claims and electronic medical record database Read More »
PATHFINDER: A Prospective Study of a Multi-Cancer Early Detection Blood Test Grail Content Editor PATHFINDER: A Prospective Study of a Multi-Cancer Early Detection Blood Test Read More »
Evaluation of Anxiety, Distress and Satisfaction With a Multi-Cancer Early Detection Test Grail Content Editor Evaluation of Anxiety, Distress and Satisfaction With a Multi-Cancer Early Detection Test Read More »
Evaluation of Cell-Free DNA Approaches for Multi-Cancer Early Detection Grail Content Editor Evaluation of Cell-Free DNA Approaches for Multi-Cancer Early Detection Read More »
Impact of MCED Screening Interval on Reduction in Late-Stage Cancer Diagnosis and Mortality Grail Content Editor Impact of MCED Screening Interval on Reduction in Late-Stage Cancer Diagnosis and Mortality Read More »
Oral Presentation: Multi-cancer detection of early-stage cancers with simultaneous tissue localization using a plasma cfDNA-based targeted methylation assay Grail Content Editor Oral Presentation: Multi-cancer detection of early-stage cancers with simultaneous tissue localization using a plasma cfDNA-based targeted methylation assay Read More »